Literature DB >> 14996155

Pasieka Illness Questionnaire: its value in primary hyperparathyroidism.

Benedikt Greutelaers1, Katrin Kullen, James Kollias, Melissa Bochner, Anthony Roberts, Garry Wittert, Janice Pasieka, Peter Malycha.   

Abstract

BACKGROUND: A prospective study was undertaken to assess the Pasieka Illness Questionnaire (PIQ) as a clinical evaluation and outcome tool in an Australian setting. The PIQ was specifically designed to assess the impact of surgery on the preoperative symptoms of patients with primary hyperparathyroidism (1 degrees HPT).
METHODS: Sixty of 71 consecutive patients referred with 1 degrees HPT completed the PIQ preoperatively and 3 months after parathyroid surgery. Fifty-four of the 60 patients filled in a 12-month follow-up questionnaire that included a quality of life (QOL) and a self-rated health uni-scale. Serum calcium, ionized calcium and parathyroid hormone levels were obtained on each occasion.
RESULTS: Eighty per cent of patients identified a significant decrease in symptoms following surgery. QOL and self-rated health improved after undergoing parathyroid surgery. Serum calcium levels returned to normal in 97% of patients 12 months after surgery.
CONCLUSIONS: The present study supports the use of the Pasieka Illness Questionnaire as a useful method to measure disease-specific symptoms in patients with 1 degrees HPT and is applicable to Australian patients. It also shows, once again, that parathyroid surgery produces a significant improvement in the preoperative symptoms of 1 degrees HPT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996155     DOI: 10.1111/j.1445-2197.2004.02907.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  5 in total

1.  Persistent symptomatic improvement in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism.

Authors:  Preethi Gopinath; Gregory P Sadler; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2010-07-25       Impact factor: 3.445

2.  Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy.

Authors:  Raghunandan Venkat; Guennadi Kouniavsky; Ralph P Tufano; Eric B Schneider; Alan P B Dackiw; Martha A Zeiger
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

Review 3.  What symptom improvement can be expected after operation for primary hyperparathyroidism?

Authors:  Nadine R Caron; Janice L Pasieka
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

4.  Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism.

Authors:  Sara E Murray; Priya R Pathak; David S Pontes; David F Schneider; Sarah C Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  Surgery       Date:  2013-10-04       Impact factor: 3.982

5.  Pasieka's parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism.

Authors:  Radu Mihai; Gregory P Sadler
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.